Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Prime Medicine, Inc. PRME

Set alert

Price alert · PRME

All alert types
4.49 USD +0.04 +1.01%

As of Nov 3, 2:43 PM ET

Bid
4.48 × 10
Ask
4.49 × 6
4.44 Day range 4.89
2.67 52-week range 5.91
YTD
+29.25%
1 year
-1.64%
Open
4.50
Prev close
4.44
Mkt cap
813.48M
Vol
2.60M
Avg vol
4.05M
EPS
-1.07
P/E
0.00
Div yield
0.00%
More statistics
Low
4.44
High
4.89
Forward P/E
-3.96
Beta
2.67
Short ratio
5.85
Inst. own
44.38%
Dividend
0.00
Ex-div date
50-d avg
4.61
200-d avg
2.96
1y target
6.50

6M chart

Chart tools
Interval
1m5m15m30m

Signals (42)
NameDateAgo
RSI: OverboughtOct 28, 20266 days ago
SMA: BullishOct 15, 20262 weeks ago
SMA: BullishOct 15, 20262 weeks ago
SMA: BearishOct 14, 20262 weeks ago
SMA: BearishOct 14, 20262 weeks ago
SMA: BullishOct 6, 20264 weeks ago
SMA: BullishOct 6, 20264 weeks ago
MACD: Buy SignalOct 6, 20264 weeks ago
SMA: BearishSep 23, 20261 month ago
SMA: BearishSep 23, 20261 month ago
SMA: BullishSep 22, 20261 month ago
SMA: BullishSep 22, 20261 month ago
SMA: BearishSep 11, 20261 month ago
SMA: BearishSep 10, 20261 month ago
MACD: Sell SignalSep 10, 20261 month ago
SMA: BullishAug 25, 20262 months ago
SMA: BullishAug 25, 20262 months ago
SMA: BearishAug 24, 20262 months ago
SMA: BearishAug 24, 20262 months ago
SMA: BullishAug 21, 20262 months ago

Newest 20 of 42.

Analyst view

Consensus: buy

Buy
Price target (mean) 6.50 +44.9% upside
Target (low)
4.00
Target (mean)
6.50
Target (high)
10.00
Ratings (0m) 11 7 buy · 4 hold · 0 sell
  • Strong buy1
  • Buy6
  • Hold4
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 11
  • 1 month ago 11
  • 2 months ago 12
  • 3 months ago 12

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

PRME analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.24724-0.33 – -0.21-0.44+43.8%2.80M+1240.1%10
Next quarter-0.2003-0.34 – -0.11-0.31+35.4%3.77M+72.6%10
Current year-1.17-1.45 – -1.06-1.65+29.3%8.73M+192.5%11
Next year-0.8659-1.51 – -0.56-1.17+25.8%24.36M+179.1%9

Upgrades and downgrades

The latest rating changes

PRME analyst upgrades and downgrades
DateFirmActionFromTo
Aug 8, 2025Chardan CapitalMaintainedBuyBuy
May 27, 2025CitigroupDowngradeBuyNeutral
May 20, 2025JMP SecuritiesMaintainedMarket OutperformMarket Outperform
May 20, 2025JP MorganDowngradeOverweightNeutral
May 20, 2025HC Wainwright & Co.DowngradeBuyNeutral
May 19, 2025Chardan CapitalMaintainedBuyBuy
Mar 20, 2025Chardan CapitalMaintainedBuyBuy
Mar 19, 2025HC Wainwright & Co.ReiteratedBuyBuy
Mar 4, 2025Citizens Capital MarketsReiteratedMarket OutperformMarket Outperform
Mar 3, 2025HC Wainwright & Co.ReiteratedBuyBuy
Mar 3, 2025Chardan CapitalMaintainedBuyBuy
Dec 10, 2024JMP SecuritiesInitiated—Market Outperform
Dec 3, 2024GuggenheimReiteratedBuyBuy
Oct 25, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 9, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 20, 2024HC Wainwright & Co.Initiated—Buy
May 16, 2024CitigroupUpgradeNeutralBuy
May 13, 2024JP MorganMaintainedOverweightOverweight
Apr 23, 2024WedbushReiteratedOutperformOutperform
Apr 22, 2024Chardan CapitalInitiated—Buy
Apr 8, 2024TD CowenInitiated—Buy
Apr 3, 2024WedbushInitiated—Outperform
Apr 2, 2024WedbushInitiated—Outperform
Mar 8, 2024JP MorganMaintainedOverweightOverweight
Mar 5, 2024GuggenheimMaintainedBuyBuy
Dec 8, 2023CitigroupInitiated—Neutral
Nov 7, 2023JP MorganMaintainedOverweightOverweight
Oct 9, 2023BMO CapitalInitiated—Outperform
Sep 6, 2023JonesTradingInitiated—Buy
Aug 14, 2023Morgan StanleyMaintainedEqual-WeightEqual-Weight